Vaxxinity Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

25.35K

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	66.00K	-491.00K	-88.15%
Dec 31, 2020	557.00K	-	-
Dec 31, 2019	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo Inc.	1.79B
SS Innovations International	16.04M
Veradigm	1.53B
Elite Pharmaceuticals	70.00M
Glass House Brands	188.29M
Northwest Biotherapeutics	1.60M
BioStem Technologies	210.49M
SANUWAVE Health	29.30M

Revenue Rankings

Vaxxinity News

8 months ago - Vaxxinity UB-312 Parkinson's Trial Results Published in Nature Medicine - GlobeNewsWire
10 months ago - Vaxxinity Issues Shareholder Letter - GlobeNewsWire
10 months ago - Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock - GlobeNewsWire
11 months ago - Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting - GlobeNewsWire
11 months ago - Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates - GlobeNewsWire
1 year ago - Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson's Disease at AD/PD™ 2024 - GlobeNewsWire
1 year ago - Vaxxinity's Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published - GlobeNewsWire
1 year ago - Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024 - GlobeNewsWire

More News